Belpointe Asset Management LLC Buys Shares of 15,487 Exelixis, Inc. $EXEL - MarketBeat
6 hours ago • Google News
Exelixis Inc (EXEL)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 10.54B
P/E Ratio
18.82
Revenue (TTM)
$ 2.23B
Volume
0
52W High
$ 49.62
52W Low
$ 25.17
Dividend Yield
0.00%
Beta
0.32
Technicals
50-Day MA
40.0062
200-Day MA
38.1187
52 Week High
49.62
52 Week Low
25.174
About EXEL
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
Employees
1147
Headquarters
Alameda, CA
CEO
Dr. Stelios Papadopoulos Ph.D.